Evidence map›Paper›PMID 30061828›Full record

ArticleFrontiers in pharmacology2018

Greensporone C, a Freshwater Fungal Secondary Metabolite Induces Mitochondrial-Mediated Apoptotic Cell Death in Leukemic Cell Lines.

Kirti S Prabhu, Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan, Ahmad N Iskandarani, Abdul Q Khan, Maysaloun Merhi, Halima E Omri, Said Dermime, Tamam El-Elimat, Nicholas H Oberlies and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. OMICS and Other Advanced Technologies in Mycological Applications.Journal of fungi (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Kirti S PrabhuTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Kodappully Sivaraman SiveenTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Shilpa KuttikrishnanTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Ahmad N IskandaraniTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Abdul Q KhanTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Maysaloun MerhiNational Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Halima E OmriNational Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Said DermimeNational Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Tamam El-ElimatDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Nicholas H OberliesDepartment of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, NC, United States.
Feras Q AlaliCollege of Pharmacy, Qatar University, Doha, Qatar.
Shahab UddinTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Hamad Medical Corporation · QANational Center for Cancer Care and Research · QAJordan University of Science and Technology · JOQatar University · QAUniversity of North Carolina at Greensboro · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic agents used in the treatment of cancer are known to develop resistance against cancer cells. Hence, there is a continuing need to investigate novel agents for the treatment and management of cancer. Antitumor activity of greensporone C (GC), a new resorcylic acid lactone isolated from an organic extract of a culture of a

Indexed as

AKTapoptosisgreensporone Cleukemiareactive oxygen species

Identifiers

PMID30061828
PMCPMC6054921
OpenAlexW2808159643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.